From: Postoperative outcomes of gastric carcinoma with lymphoid stroma
 |  | GCLS patients | Non-GCLS patients (control) | P value |
---|---|---|---|---|
n = 18 (%) | n = 357 (%) | Â | ||
Age (years, mean ± SD) |  | 71 ± 12.3 | 72 ± 11.6 | 0.60 |
Gender | Â | Â | Â | 0.70 |
Male | 14 (77.8) | 263 (73.7) | Â | |
Female | 4 (22.2) | 94 (16.3) | Â | |
Surgical procedures | Â | Â | Â | 0.11 |
TG | 10 (55.6) | 108 (30.3) | Â | |
DG | 7 (38.9) | 221 (61.9) | Â | |
PG | 1 (5.6) | 19 (7.8) | Â | |
Tumor diameter (mm, mean ± SD) |  | 25 ± 26.9 | 47.2 ± 30.8 | 0.21 |
Site of tumor | Â | Â | Â | 0.003 |
Upper third | 11 (61.1) | 72 (20.2) | Â | |
Middle third | 4 (22.2) | 175 (49.0) | Â | |
Lower third | 3 (16.7) | 110 (30.8) | Â | |
Number of tumors | Â | Â | Â | 0.92 |
Single | 17 (94.4) | 329 (92.2) | Â | |
Multiple | 1 (5.6) | 28 (7.8) | Â | |
Macroscopic type | Â | Â | Â | 0.44 |
Superficial | 9 (50.0) | 190 (53.2) | Â | |
Borrmann I1 (5.6) | 19 (5.3) | Â | Â | |
Borrmann II | 4 (22.2) | 52 (14.6) | Â | |
Borrmann III | 4 (22.2) | 68 (19.1) | Â | |
Borrmann IV | 0 (0) | 13 (3.6) | Â | |
Borrmann V | 0 (0) | 15 (4.2) | Â | |
Tumor invasion | Â | Â | Â | 0.48 |
T0 | 0 (0) | 0 (0) | Â | |
T1 | 11 (61.1) | 184 (51.5) | Â | |
T2 | 3 (16.7) | 37 (10.4) | Â | |
T3 | 0 (0) | 70 (19.6) | Â | |
T4 | 4 (22.2) | 66 (18.5) | Â | |
Number of harvested LN (mean ± SD) |  | 52 ± 29.4 | 47.3 ± 20.5 | 0.53 |
LN metastasis | Â | Â | Â | 0.94 |
Absent | 11 (61.1) | 218 (61.1) | Â | |
Present | 7 (38.9) | 139 (38.9) | Â | |
Number of positive LN (mean ± SD) |  | 1.39 ± 2.43 | 3.24 ± 7.8 | 0.01 |
Lymphatic invasion | Â | Â | Â | 0.33 |
ly0 | 10 (55.6) | 154 (43.1) | Â | |
ly1 | 2 (11.1) | 114 (31.9) | Â | |
ly2 | 4 (22.2) | 52 (14.6) | Â | |
ly3 | 2 (11.1) | 37 (10.4) | Â | |
Vascular invasion | Â | Â | Â | 0.68 |
v0 | 10 (55.6) | 180 (50.4) | Â | |
v1 | 5 (27.8) | 100 (28.0) | Â | |
v2 | 3 (16.7) | 55 (15.4) | Â | |
v3 | 0 (0) | 22 (6.2) | Â | |
Pathological stage | I | 10 (55.5) | 196 (54.9) | 0.57 |
II | 5 (27.8) | 69 (19.3) | Â | |
III | 3 (17.7) | 89 (24.9) | Â | |
IV | 0 (0) | 3 (0.8) | Â | |
EBV | Positive | 17 (94.4) | - | Â |
Negative | 1 (5.6) | - | Â |